Voya Investment Management LLC Sarepta Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 337,634 shares of SRPT stock, worth $53.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

337,634

Previous 301,771 11.88%

Holding current value

$53.3 Million

Previous $29.1 Million 50.21%

% of portfolio

0.05%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $3.36 Million - $5.08 Million	35,863 Added 11.88%	337,634 $43.7 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $6.76 Million - $12.5 Million	100,458 Added 49.9%	301,771 $29.1 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $13.8 Million - $16.6 Million	134,579 Added 201.66%	201,313 $24.4 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $1.74 Million - $2.57 Million	16,365 Added 32.49%	66,734 $7.64 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $1.04 Million - $1.37 Million	-8,810 Reduced 14.89%	50,369 $6.94 Million

Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $1.16 Million - $1.53 Million	11,547 Added 24.24%	59,179 $7.67 Million
Q3 2022 Mar 03, 2023	SELL	$75.71 - $119.24 $874,223 - $1.38 Million	-11,547 Reduced 19.51%	47,632 $5.27 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $904,355 - $1.42 Million	11,945 Added 33.47%	47,632 $5.27 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $297,840 - $420,178	-4,751 Reduced 11.75%	35,687 $2.68 Million
Q1 2022 May 16, 2022	SELL	$63.15 - $90.42 $50,583 - $72,426	-801 Reduced 1.94%	40,438 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.32 Million - $1.7 Million	17,128 Added 71.04%	41,239 $3.71 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $32,721 - $45,870	-496 Reduced 2.02%	24,111 $2.23 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $23,242 - $29,061	-335 Reduced 1.34%	24,607 $1.91 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $117,478 - $274,712	-1,626 Reduced 6.12%	24,942 $1.86 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $130,707 - $186,068	-1,041 Reduced 3.77%	26,568 $4.53 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $141,103 - $191,297	-1,110 Reduced 3.87%	27,609 $3.88 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $324,663 - $599,404	3,491 Added 13.84%	28,719 $4.61 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $80,402 - $128,480	-976 Reduced 3.72%	25,228 $2.47 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $907,492 - $1.61 Million	-11,858 Reduced 31.15%	26,204 $3.38 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $258,693 - $557,501	3,553 Added 10.3%	38,062 $2.87 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $284,901 - $385,801	2,539 Added 7.94%	34,509 $5.24 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $751,170 - $1.07 Million	-7,042 Reduced 18.05%	31,970 $3.81 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $642,798 - $982,559	6,605 Added 20.38%	39,012 $4.26 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $172,965 - $242,265	-1,500 Reduced 4.42%	32,407 $5.23 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $23.8 Million - $51 Million	-331,788 Reduced 90.73%	33,907 $4.48 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $10.5 Million - $16 Million	-194,179 Reduced 34.68%	365,695 $27.1 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $3.3 Million - $3.93 Million	-69,179 Reduced 11.0%	559,874 $31.2 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $22.5 Million - $29.7 Million	629,053	629,053 $28.5 Million

Others Institutions Holding SRPT

# of Institutions

470

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Sarepta Therapeutics, Inc. Transaction History